Product Images Rocuronium Bromide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 16 images provide visual information about the product associated with Rocuronium Bromide NDC 51662-1545 by Hf Acquisition Co Llc, Dba Healthfirst, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

VIAL LABEL - 51662 1542 1 Etomidate Injection Vial Label

VIAL LABEL - 51662 1542 1 Etomidate Injection Vial Label

This is a warning for a medication called Rocuronium (NDC 55150.226-10) which is a paralyzing agent and can cause respiratory arrest. It is important for facilities to have artificial respiration immediately available. The medication should be stored in a refrigerator between 2 to 8°C (36° to 46°F) and should not be frozen. Once removed from the refrigerator, the medication should be used within 600 days or 30 days if the vial is opened. This medication is distributed by AuroMedics Pharma LLG in E. Windsor, NJ and is made in India. This is a 100 mg per 10 mL multiple dose vial for intravenous use only.*

Serialized Label - 51662 1545 1 SERIALIZED LABEL

Serialized Label - 51662 1545 1 SERIALIZED LABEL

1 - Clinical P 1

1 - Clinical P 1

10 - Clinical P 10

10 - Clinical P 10

2 - Clinical P 2

2 - Clinical P 2

3 - Clinical P 3

3 - Clinical P 3

4 - Clinical P 4

4 - Clinical P 4

The text is a figure caption describing a graph that shows the relationship between the initial dose of Rocuronium Bromide and the time taken to achieve 80% or greater block by different age groups. The graph has median, 25th and 75th percentile, and individual values for the data. The age groups represented are 18-64 years, and greater than or equal to 65 years, and 10-12 years old. The initial doses of Rocuronium Bromide used in the study were between 0.45 and 1.2 mg/kg.*

5 - Clinical P 5

5 - Clinical P 5

This is a figure (Figure 2) that compares the duration of clinical effect of Rocuronium Bromide with respect to the initial dose of the drug administered, categorized by age groups. The data shows the median, 25th and 75th percentiles, and individual values. The X-axis represents the initial dose of the drug, while the Y-axis represents the duration of the clinical effect, in minutes. The age groups compared are those over and below 65 years of age as well as children between 3 months and 12 years old.*

6 - Clinical P 6

6 - Clinical P 6

7 - Clinical P 7

7 - Clinical P 7

8 - Clinical P 8

8 - Clinical P 8

9 - Clinical P 9

9 - Clinical P 9

T1 - Clinical T1

T1 - Clinical T1

This is a table showing the infusion rates for rocuronium bromide injection based on patient weight and drug delivery rate. The table includes various patient weights and corresponding infusion delivery rates in mL/hr. The rocuronium bromide is provided in a solution containing 0.5mg/mL and 50mg in 100 mL.*

T2 - Clinical T2

T2 - Clinical T2

This is a table showing the infusion rates for Rocuronium Bromide Injection (1mg/mL) used according to the patient's weight. The table contains columns of patient weight and drug delivery rate (mcg/kg/min) and another table with the infusion delivery rate (mL/hr). The infusion rate varies depending on the weight of the patient. The last row shows that 100mg of Rocuronium Bromide is mixed in 100 mL solution.*

T3 - Clinical T3

T3 - Clinical T3

This table provides infusion rates using Rocuronium Bromide Injection for patients of different weights to be delivered at certain drug delivery rates. The drug is delivered at a rate of mcg/kg/min, and the infusion delivery rate is represented in mL/hr. The solution contains 500mg Rocuronium Bromide in a 100mL solution.*

STRUCTURE - Structure

STRUCTURE - Structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.